R'izwan | Capital Edge
189 posts

R'izwan | Capital Edge
@Riz_Capitaledge
Capital Edge Investor 💰Global Macro Analyst 🌍 Mid/Small/SME Plays 📈 l Sector Rotation 🎯 | Multiple 10x Exits 💚 ❌️NFA | 🚨DYOR













Shaily Engineering down today because of plastic raw material costs? Let me explain why this is completely wrong: ❌ Not a commodity plastic company ✅ Precision GLP-1 pen injectors for global pharma ✅ 65-75% Canada generic semaglutide market share ✅ Take-or-pay USD contracts — polymer spikes don't kill margins here 💰 UBS target: ₹4,000 🏦 Capital Group ($2T AUM) bought 2%+ at ₹1,878 weeks ago when others sold 👤 ✅ Ace investor Ashish Kacholia holds 3.22% stake. He doesn't hold businesses he doesn't believe in. ✅ Abu Dhabi facility — 75 million pen injectors annually — already 50-60% capacity committed before ground breaks. Line 2 going commercial July 2026. The market just sold a global healthcare device company alongside pipe fittings manufacturers. This is a gift. #SHAILY #ShailyEngineering #GLP1 #Semaglutide #IndianStocks #StockMarket #MultibaggerStocks #HealthcareStocks #AshishKacholia #SmallcapStocks #NSE #BSE #InvestInIndia #StocksToBuy #PenInjectors #UBS #CapitalGroup #ValueInvesting #DYOR #IndianMarkets #nse #bse



Waiting for Viviana Power Q4 results anyone? #Vivianapower #sme #smallcap #power #energy #renewable #india #stockmarket #smallcap

